BioCentury
ARTICLE | Clinical News

Clofarex clofarabine: The companies will begin in 2H02 a European Phase I/II trial of Clofarex

June 24, 2002 7:00 AM UTC

Bioenvision Inc. (BIOV), London, U.K. Ilex Oncology Inc. (ILXO), San Antonio, Texas Product: Clofarex clofarabine Business: Cancer Therapeutic category: Cell proliferation Target: DNA Description: N...